. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
Microsoft Word - NWR 93-62_E_Q1 (Translation) No.FN-NWR 093/62 14 May 2019 Subject : Submission of Financial Statements for the first quarter ended March 31,2019 To : President The Stock Exchange of
(Translation) NEP-AC 002/2562 15 May 2019 Subject: Management Discussion and Analysis for 1st Quarter ended 31 March 2019 To : The President The Stock Exchange of Thailand Operating Result NEP Realty
period of 2018 To : The President of the Stock Exchange of Thailand The Company would like to provide details of changes in Profit and Loss as shown in the six-month period ending 30 June 2019 reviewed
Microsoft Word - NWR 75-61_E_Q1 (Translation) No.FN-NWR 075/61 15 May 2018 Subject : Submission of Financial Statements for the first quarter ended March 31,2018 To : President The Stock Exchange of
[COMPANY NAME] Ref.:EFORL020/2018 May 15, 2018 Subject: Management Discussion and Analysis for the first quarter ended 31 March 2018 To President The Stock Exchange of Thailand 1. Overview financial
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
) August 8, 2018 Re : Report the operating result for the year ended June 30 ,2018 by more than 20 percent. To : Director and Manager the Stock Exchange of Thailand Approved by the Board of Directors of
- Translation – Ref. EIC-AD026/2018 August 10, 2018 Subject Management Discussion and Analysis for the Six-Month Period Performance Ending June 30, 2018 To President The Stock Exchange of Thailand The Board of
Microsoft Word - MD&A 2Q2018 EN Final 15082018 Ref.:EFORL035/2018 August 15, 2018 Subject: Management Discussion and Analysis for the first quarter ended 30 June 2018 To President The Stock Exchange